Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
2002; 6: 89-97
Introduction
Alcohol abuse and alcoholism represent a
world-wide problem, both from a medical
and a social point of view. Alcohol dependence affects nearly 10% of the general population both in the United States 1 and in
Europe2 and the high prevalence rate of the
alcohol-related problems highlights the pub-
Acknowledgements
This review was partially supported by grants of the
Associazione Ricerca in Medicina, Bologna-Rome
Italy.
12) CIBIN M. Disulfiram, nuove strategie per un vecchio farmaco. Medicina delle Tossicodipendenze
1999; 7: 22-23, 57-60.
95
39) PALFAI T, DAVIDSON D, SWIFT R. Influence of naltrexone on cue-elicited craving among hazardous
drinkers: the moderational role of positive outcome expectancies. Exp Clin Psychopharmacol
1999; 7: 266-273.
40) K R A N Z L E R HR, T E N N E N H, P E N TA C, B O H N MJ.
Targeted naltrexone treatment of early problem
drinkers. Addict Behav 1997; 22: 431-436.
41) KRANZLER HR, VAN KIRK J. Efficacy of naltrexone
and acamprosate for alcopholism treatment: a
meta-analysis. Alcohol Clin Exp Res 2001; 25:
1335-1341.
42) KRYSTAL JH, CRAMER JA, KRAL WF, KIRK GF, ROSENBECK
RK. Naltrexone in the treatment of alcohol dependence. New Engl J Med 2001; 345: 1734-1739.
43) CROOP RS, FAULKNER EB, LABRIOLA DF. The safety
profile of naltrexone in the treatment of alcoholism. Results from a multicenter usage study.
The Naltrexone Usage Study Group. Arch Gen
Psychiatry 1997; 54: 1130-1135.
44) S ASS H, S OYKA M, M ANN K, Z IEGLGANSBERGER W.
Relapse prevention by acamprosate: results from
a placebo-controlled study on alcohol dependence. Arch Gen Psychiatry 1996; 53: 673-80.
45) PAILLE FM, GUELFI GB, PERKINS AC, ROYER RJ, STERU L,
PAROT P. Double-blind randomized multicentre trial
of acamprosate in maintaining abstinence from
alcohol. Alcohol Alcohol 1995; 30: 239-247.
46) P ETERS DH, FAULDS D. Tiapride: a review of its
pharmacology and therapeutic potential in the
management of alcohol dependence syndrome.
Drugs 1994; 47: 1010-1032.
47) S HAW GK, WALLER S, M AJUMDAR SK, A LBERTS JL,
LATHAM CJ, DUNN G. Tiapride in the prevention of
relapse in recently detoxified alcoholics. Br J
Psychiatry 1994; 165: 515-523.
34) ANTON RF, MOAK DH, WAID LR, LATHAM PK, MALCOLM
RJ, DIAS JK. Naltrexone and cognitive behavioral
therapy for the treatment of outpatient alcoholics:
results of a placebo-controlled trial. Am J
Psychiatry 1999; 156: 1758-1764.
48) GORELICK DA, PAREDES A. Effect of Fluoxetine on alcohol consumption in male alcoholics. Alcohol
Clin Exp Res 1992; 16: 261-265.
96
61) S HAW GK. Detoxification: the use of benzodiazepines. Alcohol Alcoholism 1995; 30: 765-770.
62) GALLANT DM, BISHOP MP, CAMP E TISDALE C. A sixmonth controlled evaluation of metronidazole
(Flagyl) in chronic alcoholic patients. Curr Ther
Res 1968; 10: 82-87.
97